• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像流量测定显示奥沙利铂治疗结直肠癌肝转移患者后门静脉扩张。

Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis.

机构信息

Department of Surgery, Uppsala University, 75185 Uppsala, Sweden.

出版信息

HPB (Oxford). 2013 Apr;15(4):265-72. doi: 10.1111/j.1477-2574.2012.00540.x. Epub 2012 Aug 20.

DOI:10.1111/j.1477-2574.2012.00540.x
PMID:23458313
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3608980/
Abstract

OBJECTIVES

Sinusoidal injury (SI) after oxaliplatin-based therapies for colorectal liver metastasis (CRLM) can increase postoperative morbidity. Preoperative methods to estimate SI are lacking. The aim of this study was to identify SI by evaluating portal vein haemodynamics.

METHODS

Magnetic resonance imaging flowmetry (MRIF) was used to estimate portal vein haemodynamics in 29 patients with CRLM before liver surgery. Sinusoidal injury was evaluated from resected non-tumorous liver parenchyma according to the combined vascular injury (CVI) score of ≥3.

RESULTS

All patients with SI (six of 29) received oxaliplatin; however, a significant association could not be proven (P= 0.148). Oxaliplatin-treated patients showed portal vein dilatation in both the SI and non-SI groups compared with patients who had not received oxaliplatin (Bonferroni corrected P= 0.003 and P= 0.039, respectively). Mean portal velocity tended to be lower in patients with SI compared with oxaliplatin-treated patients without SI (Bonferroni corrected P= 0.087). A mean portal velocity of ≤14.35 cm/s together with a cross-section area of ≥1.55 cm(2) was found to predict SI with sensitivity of 100% and specificity of 78%.

CONCLUSIONS

Oxaliplatin treatment was associated with portal vein dilatation. Patients with SI showed a tendency towards decreased mean portal flow velocity. This may indicate that SI is associated with an increased resistance to blood flow in the liver parenchyma. Portal vein haemodynamic variables estimated by MRIF can identify patients without SI non-invasively.

摘要

目的

奥沙利铂为基础的结直肠癌肝转移(CRLM)治疗后的窦状隙损伤(SI)会增加术后发病率。目前缺乏用于评估 SI 的术前方法。本研究旨在通过评估门静脉血流动力学来识别 SI。

方法

使用磁共振成像流量测定法(MRIF)对 29 例 CRLM 肝切除术患者术前的门静脉血流动力学进行评估。根据≥3 分的联合血管损伤(CVI)评分,从切除的非肿瘤性肝实质中评估 SI。

结果

所有患有 SI(29 例中的 6 例)的患者均接受奥沙利铂治疗;然而,未证明两者之间存在显著相关性(P=0.148)。与未接受奥沙利铂治疗的患者相比,奥沙利铂治疗患者的 SI 和非 SI 组门静脉均扩张(经 Bonferroni 校正,P=0.003 和 P=0.039)。与无 SI 的奥沙利铂治疗患者相比,SI 患者的平均门静脉速度趋于较低(经 Bonferroni 校正,P=0.087)。发现平均门静脉速度≤14.35 cm/s 时,伴有横截面积≥1.55 cm²可预测 SI,其灵敏度为 100%,特异性为 78%。

结论

奥沙利铂治疗与门静脉扩张有关。SI 患者的平均门静脉血流速度呈下降趋势。这可能表明 SI 与肝实质血流阻力增加有关。MRIF 估计的门静脉血流动力学变量可无创性识别无 SI 的患者。

相似文献

1
Magnetic resonance imaging flowmetry demonstrates portal vein dilatation subsequent to oxaliplatin therapy in patients with colorectal liver metastasis.磁共振成像流量测定显示奥沙利铂治疗结直肠癌肝转移患者后门静脉扩张。
HPB (Oxford). 2013 Apr;15(4):265-72. doi: 10.1111/j.1477-2574.2012.00540.x. Epub 2012 Aug 20.
2
Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis?门静脉高压症患者的结直肠癌手术:辅助奥沙利铂是否影响预后?
Dis Colon Rectum. 2013 May;56(5):577-85. doi: 10.1097/DCR.0b013e318286f8fc.
3
Identification of molecular pathways involved in oxaliplatin-associated sinusoidal dilatation.鉴定奥沙利铂相关的窦状隙扩张中涉及的分子途径。
J Hepatol. 2012 Apr;56(4):869-76. doi: 10.1016/j.jhep.2011.10.023. Epub 2011 Dec 24.
4
Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.预测结直肠肝转移瘤患者接受奥沙利铂为基础的化疗后发生肝窦阻塞综合征高分级病变:与肝切除术后结局的相关性。
Ann Surg. 2010 Mar;251(3):454-60. doi: 10.1097/SLA.0b013e3181c79403.
5
Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.结节性再生性增生(NRH)使接受结直肠癌肝转移切除术的患者在奥沙利铂化疗过程中出现并发症。
Eur J Surg Oncol. 2014 Aug;40(8):1016-20. doi: 10.1016/j.ejso.2013.09.015. Epub 2013 Nov 1.
6
Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.转移性结直肠癌患者中与基于奥沙利铂的化疗相关的严重肝窦阻塞
Ann Oncol. 2004 Mar;15(3):460-6. doi: 10.1093/annonc/mdh095.
7
Phase 1 study on S-1 and oxaliplatin therapy as an adjuvant after hepatectomy for colorectal liver metastases.S-1与奥沙利铂用于结直肠癌肝转移肝切除术后辅助治疗的1期研究。
Invest New Drugs. 2016 Aug;34(4):468-73. doi: 10.1007/s10637-016-0356-5. Epub 2016 May 7.
8
Perioperative chemotherapy with bevacizumab and liver resection for colorectal cancer liver metastasis.贝伐珠单抗联合肝切除术治疗结直肠癌肝转移的围手术期化疗。
HPB (Oxford). 2010 Feb;12(1):37-42. doi: 10.1111/j.1477-2574.2009.00119.x.
9
Effect of preoperative chemotherapy on liver resection for colorectal liver metastases.术前化疗对结直肠癌肝转移肝切除的影响。
Eur J Surg Oncol. 2008 Jul;34(7):782-6. doi: 10.1016/j.ejso.2007.09.007. Epub 2007 Dec 21.
10
Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy.在接受术前化疗的结直肠癌肝转移患者中,肝血窦损伤会增加大肝切除术后的发病率。
Ann Surg. 2008 Jan;247(1):118-24. doi: 10.1097/SLA.0b013e31815774de.

引用本文的文献

1
Peroxisome Dysfunction and Steatotic Liver Disease.过氧化物酶体功能障碍与脂肪性肝病
Int J Mol Sci. 2025 Aug 27;26(17):8303. doi: 10.3390/ijms26178303.
2
Drug-induced hepatic sinusoidal obstruction syndrome: current advances and future perspectives.药物性肝窦阻塞综合征:当前进展与未来展望
Arch Toxicol. 2025 Mar;99(3):835-850. doi: 10.1007/s00204-024-03950-9. Epub 2024 Dec 24.
3
Impact of reconstructed portal vein morphology on postoperative nutritional status in pancreatoduodenectomy: a computational fluid dynamics study.重建门静脉形态对胰十二指肠切除术后营养状况的影响:一项计算流体动力学研究
Surg Today. 2025 Mar;55(3):445-451. doi: 10.1007/s00595-024-02903-0. Epub 2024 Jul 30.

本文引用的文献

1
Accuracy of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of sinusoidal obstruction syndrome in patients with chemotherapy-treated colorectal liver metastases.钆塞酸增强磁共振成像诊断化疗治疗结直肠癌肝转移患者的窦阻塞综合征的准确性。
Eur Radiol. 2012 Apr;22(4):864-71. doi: 10.1007/s00330-011-2333-x. Epub 2011 Nov 23.
2
Chemotherapy before liver resection of colorectal metastases: friend or foe?结直肠转移瘤肝切除术前化疗:是敌是友?
Ann Surg. 2012 Feb;255(2):237-47. doi: 10.1097/SLA.0b013e3182356236.
3
The value of pre-operative magnetic resonance spectroscopy in the assessment of steatohepatitis in patients with colorectal liver metastasis.术前磁共振波谱分析在结直肠癌肝转移患者肝脂肪性肝炎评估中的价值。
J Hepatol. 2012 Mar;56(3):640-6. doi: 10.1016/j.jhep.2011.10.006. Epub 2011 Oct 23.
4
Splenomegaly in FOLFOX-naïve stage IV or recurrent colorectal cancer patients due to chemotherapy-associated hepatotoxicity can be predicted by the aspartate aminotransferase to platelet ratio before chemotherapy.化疗相关性肝毒性所致 FOLFOX 初治或复发性结直肠癌患者的脾肿大可通过化疗前的天冬氨酸转氨酶与血小板比值预测。
Int J Clin Oncol. 2011 Jun;16(3):257-63. doi: 10.1007/s10147-010-0176-0. Epub 2011 Jan 18.
5
Sinusoidal obstruction syndrome impairs long-term outcome of colorectal liver metastases treated with resection after neoadjuvant chemotherapy.新辅助化疗后切除治疗结直肠肝转移瘤的患者中,窦性阻塞综合征会损害长期预后。
Ann Surg Oncol. 2011 Feb;18(2):421-30. doi: 10.1245/s10434-010-1317-4. Epub 2010 Sep 16.
6
Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis.窦状隙阻塞综合征和结节性再生性增生是奥沙利铂相关的常见肝脏病变,贝伐珠单抗可部分预防结直肠肝转移患者的此类肝脏病变。
Histopathology. 2010 Mar;56(4):430-9. doi: 10.1111/j.1365-2559.2010.03511.x.
7
Chemotherapy-induced liver injury in metastatic colorectal cancer: semiquantitative histologic analysis of 334 resected liver specimens shows that vascular injury but not steatohepatitis is associated with preoperative chemotherapy.转移性结直肠癌的化疗性肝损伤:对 334 例切除肝脏标本的半定量组织学分析表明,血管损伤而非脂肪性肝炎与术前化疗相关。
Am J Surg Pathol. 2010 Jun;34(6):784-91. doi: 10.1097/PAS.0b013e3181dc242c.
8
Oxaliplatin-mediated increase in spleen size as a biomarker for the development of hepatic sinusoidal injury.奥沙利铂介导的脾脏增大可作为肝窦损伤发展的生物标志物。
J Clin Oncol. 2010 May 20;28(15):2549-55. doi: 10.1200/JCO.2009.27.5701. Epub 2010 Apr 20.
9
Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.预测结直肠肝转移瘤患者接受奥沙利铂为基础的化疗后发生肝窦阻塞综合征高分级病变:与肝切除术后结局的相关性。
Ann Surg. 2010 Mar;251(3):454-60. doi: 10.1097/SLA.0b013e3181c79403.
10
Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury.与奥沙利铂给药相关的门静脉高压:肝窦损伤的临床表现
Clin Colorectal Cancer. 2009 Oct;8(4):225-30. doi: 10.3816/CCC.2009.n.038.